ePlus Inc. filings document a Nasdaq-listed technology solutions provider with common stock registered under the Exchange Act. Recent Form 8-K reports cover operating results, GAAP and non-GAAP financial measures, quarterly cash dividends, and the presentation of discontinued operations after the completed sale of the company's domestic financing business.
The filings also record governance and capital-structure matters, including amended and restated bylaws, board and committee composition, director compensation references, annual meeting voting results, auditor ratification, executive-compensation advisory votes, and registration statement incorporation of recast financial information.
Elaine D. Marion, EPlus Inc.'s chief financial officer, reported that Elaine D. Marion Trust sold 5,000 common shares across four transactions on October 12 and 13, 2026, under a Rule 10b5-1 trading plan adopted November 18, 2025. The reported prices were $95.0357 per share for 158 shares on October 12, and $95.7286 for 2,120 shares, $96.7169 for 2,377 shares, and $97.3888 for 345 shares on October 13. Elaine D. Marion and her spouse are the revocable trust's sole trustees and beneficiaries.
Elaine D. Marion, identified as an officer of ePlus Inc. (PLUS), reported a proposed sale of 4,842 common shares through Rockefeller Capital Management, with an aggregate market value of $466,439.74 and an approximate sale date of October 13, 2026. The notice lists four prior sales from Elaine D Marion Rev Trust: 2,818 shares on July 29, 2026; 1,668 on August 3, 2026; 5,514 on August 4, 2026; and 158 on October 12, 2026.
ePlus Inc. officer Marion Elaine D reported 158 common shares for sale, with a listed value of $15,000.47. The remarks say the shares were sold on October 12, 2026, from the ELAINE D MARION REV TRUST. Earlier sales listed for the prior three months were 2,818 shares on July 29, 1,668 on August 3, and 5,514 on August 4, 2026.
ePlus Inc. director Michael J. Portegello was granted 1,201 restricted shares on October 1, 2026, under the company's 2024 Non-Employee Director Long Term Incentive Plan. His direct common-stock holdings following the award were 2,095 shares. The shares are subject to a restriction period beginning on the grant date and ending on its first anniversary or, if earlier, on the date of the company's next annual stockholder meeting.
EPLUS Inc. director Maureen F. Morrison acquired 1,201 shares of common stock on October 1, 2026, as a restricted stock award under the company’s 2024 Non-Employee Director Long Term Incentive Plan. The restriction period ends on the first anniversary of the grant or, if earlier, the date of the company’s next annual stockholder meeting. Her direct holdings after the award were 15,039 shares.
EPLUS Inc. director John Mark Lutz acquired 1,201 shares of restricted common stock as an award on October 1, 2026. His direct holdings following the award were 1,510 shares. The award was granted under the company's 2024 Non-Employee Director Long Term Incentive Plan, with a restriction period ending on the first anniversary of the grant or, if earlier, on the date of the next annual stockholder meeting.
EPLUS Inc. director Ira A. Hunt received a restricted stock award of 1,201 common shares on October 1, 2026. His reported directly held common shares following the award were 29,007. The award was granted under the 2024 Non-Employee Director Long Term Incentive Plan, and its restriction period ends on the first anniversary of the grant or, if earlier, on the date of the next annual stockholder meeting after the grant.
Eplus Inc. director John E. Callies acquired 1,201 shares of restricted common stock on October 1, 2026, under the company’s 2024 Non-Employee Director Long Term Incentive Plan. His direct holdings following the award were 21,849 shares. The restriction period runs from the grant date through its first anniversary, or earlier, the date of the company’s next annual stockholder meeting following the grant.
ePlus Inc. director Bruce M. Bowen acquired 1,201 common shares as a restricted stock award and received 232 common shares in lieu of cash compensation on October 1, 2026. The 1,201 restricted shares are subject to a restriction period ending on the first anniversary of the grant or, if earlier, the date of the next annual stockholder meeting after the grant. Reported indirect holdings as of October 1, 2026 include 14,205 shares in Bruce Montague Bowen Trust, 1,084 shares in Elizabeth Dederich Bowen Trust, and 9,255 shares in Bowen Holdings LLC.
EPLUS Inc. director Renee Bergeron received a restricted stock award of 1,201 common shares on October 1, 2026, under the company’s 2024 Non-Employee Director Long Term Incentive Plan. Her direct holdings after the award were 6,973 shares. The shares are subject to a restriction period beginning on the grant date and ending on its first anniversary, or earlier on the date of the next annual stockholder meeting.